Stocks
Alexandria Real Estate Equities, Inc.ARE
NYSEReal EstateREIT—Office$48.41-3.66%
Specializing in life science and technology campuses, this REIT owns and operates collaborative properties for pharmaceutical, biotech, and agtech tenants. Its focus on high-barrier-to-entry markets like Boston and San Francisco makes it a key player in lab space real estate. Investors monitor ARE for exposure to the growing life sciences sector and its premium urban locations.
Market Cap: $8.4B52W Range: $44.10 – $101.22
Congressional Interest in Alexandria Real Estate Equities, Inc. (ARE)
7 members of Congress have disclosed 50 trades in Alexandria Real Estate Equities, Inc. (ARE), a Real Estate company. The buy/sell breakdown shows 24 purchases versus 26 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
7
Buys
24
Sells
26
Who in Congress Is Trading ARE?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-23 | Rohit Khanna | sell | $1K – $15K |
| 2026-03-23 | MICHAEL T. MCCAUL | buy | $50K – $100K |